These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6792080)
41. Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. Rao AR; Laxova A; Farrell PM; Barbieri JT J Clin Microbiol; 2009 Aug; 47(8):2483-8. PubMed ID: 19553571 [TBL] [Abstract][Full Text] [Related]
42. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082 [TBL] [Abstract][Full Text] [Related]
43. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection. Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319 [TBL] [Abstract][Full Text] [Related]
44. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis. Shryock TR; Mollé JS; Klinger JD; Thomassen MJ J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922 [TBL] [Abstract][Full Text] [Related]
45. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients. Pier GB J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328 [No Abstract] [Full Text] [Related]
47. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. Döring G; Obernesser HJ; Botzenhart K; Flehmig B; Høiby N; Hofmann A J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993 [TBL] [Abstract][Full Text] [Related]
48. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity. Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907 [TBL] [Abstract][Full Text] [Related]
49. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases. Holby N; Olling S Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841 [TBL] [Abstract][Full Text] [Related]
50. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Fomsgaard A; Høiby N; Shand GH; Conrad RS; Galanos C Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536 [TBL] [Abstract][Full Text] [Related]
51. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884 [TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [TBL] [Abstract][Full Text] [Related]
53. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa. Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670 [TBL] [Abstract][Full Text] [Related]
54. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. Pier GB; Takeda S; Grout M; Markham RB J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038 [TBL] [Abstract][Full Text] [Related]